BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35813762)

  • 1. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation.
    Park HS; Detterbeck FC; Madoff DC; Bade BC; Kumbasar U; Mase VJ; Li AX; Blasberg JD; Woodard GA; Brandt WS; Decker RH
    J Thorac Dis; 2022 Jun; 14(6):2412-2436. PubMed ID: 35813762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.
    Detterbeck FC; Mase VJ; Li AX; Kumbasar U; Bade BC; Park HS; Decker RH; Madoff DC; Woodard GA; Brandt WS; Blasberg JD
    J Thorac Dis; 2022 Jun; 14(6):2357-2386. PubMed ID: 35813747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.
    Bade BC; Blasberg JD; Mase VJ; Kumbasar U; Li AX; Park HS; Decker RH; Madoff DC; Brandt WS; Woodard GA; Detterbeck FC
    J Thorac Dis; 2022 Jun; 14(6):2387-2411. PubMed ID: 35813753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 1: a guide to decision-making.
    Detterbeck FC; Blasberg JD; Woodard GA; Decker RH; Kumbasar U; Park HS; Mase VJ; Bade BC; Li AX; Brandt WS; Madoff DC
    J Thorac Dis; 2022 Jun; 14(6):2340-2356. PubMed ID: 35813719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands.
    de Ruiter JC; Heineman DJ; Daniels JM; van Diessen JN; Damhuis RA; Hartemink KJ
    Lung Cancer; 2020 Jun; 144():64-70. PubMed ID: 32371262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer.
    Ezer N; Veluswamy RR; Mhango G; Rosenzweig KE; Powell CA; Wisnivesky JP
    J Thorac Oncol; 2015 Aug; 10(8):1201-6. PubMed ID: 26200275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.
    Alberts L; Wolff HB; Kastelijn EA; Lagerwaard FJ; Hofman FN; Sharouni SYE; Schramel FMNH; Coupe VMH
    Clin Lung Cancer; 2019 Sep; 20(5):370-377.e3. PubMed ID: 31182416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review.
    Iovoli AJ; Yu B; Ma SJ; Farrugia MK; Dexter EU; Yendamuri S; Bouchard EG; Singh AK
    JTO Clin Res Rep; 2022 Nov; 3(11):100417. PubMed ID: 36325154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.
    Li M; Yang X; Chen Y; Yang X; Dai X; Sun F; Zhang L; Zhan C; Feng M; Wang Q
    Onco Targets Ther; 2017; 10():2885-2892. PubMed ID: 28652770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.
    Zhang R; Kang J; Ren S; Xing L; Xu Y
    Ann Transl Med; 2022 Jan; 10(2):104. PubMed ID: 35282118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
    J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
    Uhlig A; Uhlig J; Trojan L; Kim HS
    J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation
    Li M; Xu X; Qin Y; Zhang P; Shen C; Xia Q; Fan L
    J Cancer; 2021; 12(10):3057-3066. PubMed ID: 33854605
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.
    Bryant AK; Mundt RC; Sandhu AP; Urbanic JJ; Sharabi AB; Gupta S; Daly ME; Murphy JD
    Ann Thorac Surg; 2018 Feb; 105(2):425-431. PubMed ID: 29198624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage video-assisted thoracoscopic lobectomy for isolated local relapse after stereotactic body radiotherapy for early stage non-small cell lung cancer: technical aspects and perioperative management.
    Hamaji M; Chen-Yoshikawa TF; Matsuo Y; Motoyama H; Hijiya K; Menju T; Aoyama A; Sato T; Sonobe M; Date H
    J Vis Surg; 2017; 3():86. PubMed ID: 29302412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
    Lin Q; Sun X; Zhou N; Wang Z; Xu Y; Wang Y
    BMC Pulm Med; 2019 May; 19(1):98. PubMed ID: 31118007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.